Search

everythinglearnresearchcommunity

for

Search:↓

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

Hydroxychloroquine may cause false results in tuberculosis tests for patients with autoimmune skin diseases.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Watching, not removing, skin growths with moderate atypia and positive edges is okay; patients may get melanoma elsewhere, especially if they've had it before.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Gut health affects skin diseases, and probiotics might help.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

PDE inhibitors, especially PDE4 inhibitors like apremilast, are effective for certain inflammatory skin conditions but have side effects and can be costly.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Dovobet ointment used overnight effectively reduces scalp psoriasis severity and itch.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Turmeric may have benefits for skin health, but more research is needed to confirm its effectiveness.

Bergamot may improve heart health, skin conditions, and mood, but more research is needed to confirm these benefits.

The British Association of Dermatologists celebrated 100 years by looking back at important research, including work on hair loss, skin condition impact, psoriasis treatment, and skin cancer rates.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.